These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10520722)

  • 1. Attribution of use of perchlorate in parathyroid scintigraphy.
    Fjeld JG
    J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520722
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of perchlorate in parathyroid scintigraphy.
    Lyngbye J
    J Nucl Med; 1998 Jul; 39(7):1306. PubMed ID: 9669417
    [No Abstract]   [Full Text] [Related]  

  • 3. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid scintigraphy.
    Prekeges JL; Eisenberg B
    J Nucl Med Technol; 1997 Mar; 25(1):59-65. PubMed ID: 9239607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of parathyroid hyperplasia, lymph node metastasis from thyroid cancer, and thyroid adenomatous hyperplasia using Tc-99m MIBI.
    Nakai T; Okuyama C; Kubota T; Kobayashi K; Ushijima Y; Nishimura T
    Clin Nucl Med; 2003 Dec; 28(12):984-5. PubMed ID: 14663323
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
    Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
    Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
    Nguyen BD
    Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-sestamibi/thallium-201 mismatch of thyroid and parathyroid adenoma in chronic renal failure.
    Pijpers R; van Loon BJ; Roos JC; Hoekstra OS
    J Nucl Med; 1995 May; 36(5):826-8. PubMed ID: 7738659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo test of thyroid radioactive iodide uptake, pertechnetate 99m uptake and thyroid scintigraphy].
    Ochi Y; Kajita Y
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():317-20. PubMed ID: 9172537
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
    Hod N; Strauss S; Horne T
    Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization.
    Sabet A; Ahmadzadehfar H; Muckle M; Haslerud T; Wilhelm K; Biersack HJ; Ezziddin S
    J Nucl Med; 2011 Jul; 52(7):1063-7. PubMed ID: 21680693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings.
    Burke GJ; Wei JP; Binet EF
    AJR Am J Roentgenol; 1993 Dec; 161(6):1265-8. PubMed ID: 8249740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hemiagenesis.
    Sari O; Ciftçi I; Törü M; Erbaş B
    Clin Nucl Med; 2000 Oct; 25(10):766-8. PubMed ID: 11043712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodized contrast: a possible confusion factor in parathyroid dual-tracer scintigraphy.
    Loira FJ; Alvarez AM; Serena A; Pou JL; Nogueiras JM; Campos LM
    Clin Nucl Med; 2010 Mar; 35(3):178-80. PubMed ID: 20173451
    [No Abstract]   [Full Text] [Related]  

  • 17. Technetium-99m-pertechnetate uptake by intrathyroidal parathyroid adenoma.
    Leslie WD; Riese KT; Guzman R; Dupont JO; Peterdy AE
    J Nucl Med; 1996 May; 37(5):861-2. PubMed ID: 8965164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
    Aigner RM; Fueger GF; Lax S
    Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter.
    Kotzerke J; Fenchel S; Guhlmann A; Stabin M; Rentschler M; Knapp FF; Reske SN
    Nucl Med Commun; 1998 Aug; 19(8):795-801. PubMed ID: 9751935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary adenocarcinoma as a random finding in (99m)Tc-MIBI parathyroid scintigraphy.
    Behrendt FF; Verburg FA; Prechtel HW; Mottaghy FM; Krohn T
    Hell J Nucl Med; 2012; 15(3):254-5. PubMed ID: 23227463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.